Back to All Events

Pediatric Advisory Committee and Drug Safety and Risk Management Advisory Committee

The committees will meet to discuss a pediatric-focused safety review of neuropsychiatric events with use of Singulair (montelukast).

Earlier Event: September 26
Pediatric Advisory Committee and the Drug Safety and Risk Management Advisory Committee
Later Event: October 7
Science Board to the FDA